NCT01491737 2020-10-28
PERTAIN
Hoffmann-La Roche
Phase 2 Completed
Clinical Trials
3 trialsNCT00943553 2015-04-13
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Eisai Inc.
Phase 2 Withdrawn
NCT00460551 2011-12-06
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
Genmab
Phase 2 Terminated